FORWARD PHARMA A/S's ticker is FWP and the CUSIP is 34986J105. A total of 35 filers reported holding FORWARD PHARMA A/S in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $1,192,000 | -67.9% | 62,769 | -60.1% | 0.29% | -68.7% |
Q3 2015 | $3,708,000 | -38.6% | 157,397 | -0.8% | 0.92% | -33.4% |
Q2 2015 | $6,037,000 | +1.2% | 158,660 | -24.7% | 1.38% | +26.9% |
Q1 2015 | $5,964,000 | +64.9% | 210,604 | +21.3% | 1.09% | +61.5% |
Q4 2014 | $3,616,000 | – | 173,622 | – | 0.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Monashee Investment Management LLC | 100,000 | $2,356,000 | 16.27% |
BVF INC/IL | 1,016,324 | $23,945,000 | 4.84% |
Baupost Group | 5,367,300 | $126,454,000 | 2.11% |
Cormorant Asset Management, LP | 335,068 | $7,894,000 | 1.26% |
EcoR1 Capital, LLC | 101,995 | $2,403,000 | 1.09% |
HELLMAN JORDAN MANAGEMENT CO INC /MA/ | 157,397 | $3,708,000 | 0.92% |
Assured Investment Management LLC | 1,102,924 | $25,985,000 | 0.48% |
SPHERA FUNDS MANAGEMENT LTD. | 135,000 | $3,181,000 | 0.41% |
CLOUGH CAPITAL PARTNERS L P | 260,300 | $6,133,000 | 0.26% |
Orbimed Advisors | 960,600 | $22,632,000 | 0.23% |